Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)Release Date:Partner: American Society for Clinical Pathology (ASCP)Quality Improvement Oncology USA Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factorsRelease Date:Quality Improvement, Research Oncology Italy Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-TRelease Date:Research Oncology USA Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada Title Grant Type Focus Area Country Application Due Date Real World Experience with Biosimilar Medicines in OncologyRelease Date:Education Oncology All Education of Healthcare Professionals to Provide Appropriate Medical Care for IBD PatientsRelease Date:Education Inflammation & Immunology Japan Improving COVID-19 Outpatient Management (Emerging market countries listed in Geographic Scope)Release Date:Quality Improvement Hospital All Quality Improvement in Pediatric Endocrinology fieldsRelease Date:Partner: The Japanese Society for Pediatric EndocrinologyQuality Improvement Rare Disease Japan COVID-19 Patient Awareness (United States and Europe)Release Date:Education Hospital All Improving Cytogenetic Testing & Treatment Guidance in Adult AMLRelease Date:Quality Improvement Oncology Canada Acromegaly Research- United StatesRelease Date:Research Rare Disease USA Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in CanadaRelease Date:Research Rare Disease Canada Best Practices in the Clinical Management of Patients with BRAF-mutant Metastatic MelanomaRelease Date:Education Oncology USA Innovative Solutions in Atopic Dermatitis and Alopecia Areata Management 2022 I&I IT INNOVA-DERMARelease Date:Quality Improvement Inflammation & Immunology Italy ASTRO-Myovant Sciences-Pfizer Alliance New Combination Therapy ChallengeResearch Oncology USA Early Diagnosis of Invasive Fungal Infections (Emerging market countries listed in Geographic Scope)Release Date:Research Hospital All